Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin.
Saved in:
| Title: | Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients Unresponsive to Rituximab and Intravenous Immunoglobulin. |
|---|---|
| Authors: | Ban, Tae Hyun1 (AUTHOR), Lee, Sua2 (AUTHOR), Kim, Hyung Duk3 (AUTHOR), Ko, Eun Jeong3 (AUTHOR), Kim, Bo-Mi4,5 (AUTHOR), Kim, Kyoung-Woon6 (AUTHOR), Chung, Byung Ha3,4,5 (AUTHOR), Yang, Chul Woo3,4,5 (AUTHOR) |
| Source: | Stem Cells International. 2/11/2021, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1687966X |
|---|---|
| DOI: | 10.1155/2021/6672644 |
